Margareta Elisabeth Björk
Director/Board Member bei PHARVARIS N.V.
Vermögen: 503 080 $ am 30.04.2024
Aktive Positionen von Margareta Elisabeth Björk
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.06.2012 | - |
| ROCKET PHARMACEUTICALS, INC. | Director/Board Member | 20.04.2020 | - |
| Independent Dir/Board Member | 20.04.2020 | - | |
| PHARVARIS N.V. | Director/Board Member | 01.12.2021 | - |
| Independent Dir/Board Member | 01.12.2021 | - | |
| CALLIDITAS THERAPEUTICS AB | Director/Board Member | 01.01.2022 | - |
| Independent Dir/Board Member | 01.01.2022 | - | |
| VICORE PHARMA HOLDING AB | Director/Board Member | 01.01.2023 | - |
| University of Uppsala | Corporate Officer/Principal | - | - |
| Chalmers University of Technology | Director/Board Member | - | - |
| Björks Matematik o Mera AB | Director/Board Member | - | - |
| Rfidcompare Europe AB | Director/Board Member | - | - |
Karriereverlauf von Margareta Elisabeth Björk
Ehemalige bekannte Positionen von Margareta Elisabeth Björk
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Margareta Elisabeth Björk
| Karolinska Institutet | Doctorate Degree |
| University of Uppsala | Doctorate Degree |
Statistik
International
| Schweden | 9 |
| Vereinigtes Königreich | 3 |
| Niederlande | 2 |
Operativ
| Director/Board Member | 8 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 3 |
Sektoral
| Health Technology | 7 |
| Consumer Services | 4 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| PHARVARIS N.V. | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Health Technology |
Uppsala University Hospital
 Uppsala University Hospital Hospital/Nursing ManagementHealth Services Uppsala University Hospital operates a hospital. | Health Services |
| Björks Matematik o Mera AB | |
| Rfidcompare Europe AB |
